The mission of the Division of Pharmacotherapy and Experimental Therapeutics is to optimize drug therapy through the generation, integration, and translation of scientific information between the bench and the bedside, the patient and the population. The Division advances clinical practice by leading the nation’s pharmacy schools in innovative translational research, and through the education and training of clinical scientists, future pharmacists and current practitioners.

Graduate Student Schuck Receives TraC$2K Grant

Bob Schuck, PharmD, a graduate student at the UNC Eshelman School of Pharmacy, has received a $2,000 grant from the North Carolina Translational and Clinical Sciences Institute for research looking into the role of an enzyme in the development of cardiovascular disease.

DNA Direct Founder to Receive UNC IPIT Patient-Care Award

Ryan Phelan, CEO and founder of DNA Direct, is this year’s recipient of the Award for Patient Service from the Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina at Chapel Hill.

Craig Lee Receives NIH Grant to Find New Inflammation Treatment

The grant, worth up to $1.55 million over five years, will fund research investigating the role of a family of enzymes called cytochromes P450 — CYP for short — in the regulation of inflammatory responses in the liver and other tissues.